pone.0261955.s002.docx (22.38 kB)

List of hospital / institutions participating in the study.

journal contribution

posted on 2021-12-31, 18:50 authored by Roberto Gallego-Pinazo, Begoña Pina-Marin, Marta Comellas, Susana Aceituno, Laia Gómez-Baldó, Carles Blanch

(DOCX)

History

Usage metrics

PLOS ONE

Categories

Keywords

without previous experience two focus groups related macular degeneration mixed logit model intravitreal injections represents discrete choice experiment action may contribute specialists &# 8217 reverses visual damage permanent visual impairment frequent monitoring visits retina specialists working 66 retina specialists aligning treatment characteristics p ); 52 p ); 27 p ); 13 delaying monitoring frequency treatment monitoring requirements xlink "> efficacy calculated taking cost 5 %, respectively namd treatment characteristics namd receiving anti visual function improvements least 2 years retina specialists visual function monitoring frequency xlink ">cost );treatment regimen treatment election although treatment unmet needs significant burden select one retinal fluid results suggest relative importance neovascular age marginal rates main driver longer duration functional independence five attributes estimated using efficacious anti also considered aged 79 50 years

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC